Search

Your search keyword '"K. Sexton"' showing total 293 results

Search Constraints

Start Over You searched for: Author "K. Sexton" Remove constraint Author: "K. Sexton"
293 results on '"K. Sexton"'

Search Results

151. Unanswered questions, the epidemiology of a community outbreak: meningococcal C disease in Northland, New Zealand, 2011.

152. Fluorescent affibody peptide penetration in glioma margin is superior to full antibody.

153. An outbreak of Salmonella Typhimurium phage type 42 associated with the consumption of raw flour.

154. Biomarkers of maternal and fetal exposure to organochlorine pesticides measured in pregnant Hispanic women from Brownsville, Texas.

155. Biomarker measurements of prenatal exposure to polychlorinated biphenyls (PCB) in umbilical cord blood from postpartum Hispanic women in Brownsville, Texas.

156. Gene and protein responses of human lung tissue explants exposed to ambient particulate matter of different sizes.

157. High vascular delivery of EGF, but low receptor binding rate is observed in AsPC-1 tumors as compared to normal pancreas.

158. Application of a novel method for assessing cumulative risk burden by county.

159. Impact of Hispanic ethnic concentration and socioeconomic status on obesity prevalence in Texas counties.

160. Cumulative risk assessment: an overview of methodological approaches for evaluating combined health effects from exposure to multiple environmental stressors.

161. Rickettsia felis infections, New Zealand.

162. Using exposure biomarkers in children to compare between-child and within-child variance and calculate correlations among siblings for multiple environmental chemicals.

163. Spatial analysis of county-level breast cancer mortality in Texas.

164. Conceptual models for cumulative risk assessment.

165. Cumulative risk assessment for combined health effects from chemical and nonchemical stressors.

166. Proteomic profiling of human respiratory epithelia by iTRAQ reveals biomarkers of exposure and harm by tobacco smoke components.

167. A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer.

168. Polycyclic aromatic hydrocarbons in maternal and umbilical cord blood from pregnant Hispanic women living in Brownsville, Texas.

169. Epigenetic mechanisms of mouse interstrain variability in genotoxicity of the environmental toxicant 1,3-butadiene.

170. Surgical skin markers impair human saphenous vein graft smooth muscle and endothelial function.

171. Epigenetic alterations in liver of C57BL/6J mice after short-term inhalational exposure to 1,3-butadiene.

172. Daily activities and sleep quality in young adults.

173. Biomarker measurements of concurrent exposure to multiple environmental chemicals and chemical classes in children.

174. Burden of disease attributed to anthropogenic air pollution in the United Arab Emirates: estimates based on observed air quality data.

175. The role of cumulative risk assessment in decisions about environmental justice.

176. Rational design of a topical androgen receptor antagonist for the suppression of sebum production with properties suitable for follicular delivery.

177. The TNF-like protein 1A-death receptor 3 pathway promotes macrophage foam cell formation in vitro.

178. Airborne particles in Swansea, UK: their collection and characterization.

179. Acute gastrointestinal illness in New Zealand: information from a survey of community and hospital laboratories.

180. Identification of novel kinase targets for the treatment of estrogen receptor-negative breast cancer.

181. A novel application for Cocoacrisp protein as a biomarker for experimental pulmonary fibrosis.

182. Henoch-Schönlein purpura and meningococcal B vaccination.

183. Genomic biomarkers of pulmonary exposure to tobacco smoke components.

184. Wide geographical distribution of internationally rare Campylobacter clones within New Zealand.

185. Cumulative cancer risk from air pollution in Houston: disparities in risk burden and social disadvantage.

186. Surveillance of vaccine breakthrough cases following MeNZB vaccination.

187. Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients.

188. An in vitro approach to assess the toxicity of inhaled tobacco smoke components: nicotine, cadmium, formaldehyde and urethane.

189. Issues and opportunities for retaining experienced nurses at the bedside.

190. Relationships between personal, indoor, and outdoor exposures to trace elements in PM(2.5).

191. Combustion-derived nanoparticles: mechanisms of pulmonary toxicity.

192. Comparative assessment of air pollution-related health risks in Houston.

193. Post-marketing safety monitoring of a new group B meningococcal vaccine in New Zealand, 2004-2006.

194. Serum leptin concentration, adiposity, and body fat distribution in Mexican-Americans.

195. If cumulative risk assessment is the answer, what is the question?

196. Assessing cumulative health risks from exposure to environmental mixtures - three fundamental questions.

197. Nursing support, workload, and intent to stay in Magnet, Magnet-aspiring, and non-Magnet hospitals.

198. Utility of personality measurement of clinic patients with insomnia.

199. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane.

200. Estimating volatile organic compound concentrations in selected microenvironments using time-activity and personal exposure data.

Catalog

Books, media, physical & digital resources